Bryan G Barnosky, D.O. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 50505 Schoenherr Rd, Suite 290, Shelby Township, MI 48315 Phone: 586-314-0080 Fax: 586-731-6257 |
Shelley Marie Schendel, D.O. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 50505 Schoenherr Rd, Suite 290, Shelby Township, MI 48315 Phone: 586-314-0080 Fax: 586-731-6257 |
Dr. Joseph Mardelli, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 50505 Schoenherr Rd Ste 290, Shelby Township, MI 48315 Phone: 586-314-0080 Fax: 586-731-6257 |
News Archive
The percentage of African ancestry in a person's genome determines the level that certain genes are expressed, called mRNA, according to a new Northwestern Medicine study.
The age-old question of whether pride is the seventh sin or an adaptive virtue has been answered by two Northeastern University scientists.
Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced the initiation of a Phase I clinical trial of TRV120027, a titratable i.v. agent designed for the treatment of acute decompensated heart failure. TRV120027 is a biased ligand that targets the angiotensin II type 1 receptor (AT1R) and induces a unique mode of signaling.
As part of an effort to develop effective medical therapies that block the progression of liver cyst growth in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), researchers at the University of Colorado Anschutz Medical Center have found that the liver cyst walls develop and maintain a vasculature as they grow out from the body of the liver and that factors released by epithelial cells that line the liver cyst wall lumen can drive the proliferation and development of vascular endothelial cells.
› Verified 4 days ago